MLAB
Mesa Laboratories, Inc.78.63
+0.80+1.03%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
434.22MP/E (TTM)
-Basic EPS (TTM)
-0.31Dividend Yield
0.01%Recent Filings
10-Q
8-K
8-K
Mesa's annual meeting outcomes
Mesa Laboratories held its annual shareholder meeting on August 22, 2025, electing John J. Sullivan, Gary M. Owens, Jenny S. Alltoft, Shannon M. Hall, Shiraz S. Ladiwala, R. Tony Tripeny, and Mark C. Capone to its board for a one-year term. Shareholders ratified Baker Tilly US, LLP as independent auditors for the fiscal year ending March 31, 2026, approved executive compensation on a non-binding basis, and passed an amendment to the 2021 Equity Incentive Plan. All proposals garnered strong support, with over 90% votes in favor for director elections and ratification. The refreshed board signals steady governance continuity.
8-K
Mesa repays notes via credit draw
Mesa Laboratories drew $97 million under its existing credit facility on August 12, 2025, to repay $97.5 million in maturing convertible notes on August 15, leaving $108 million outstanding at a 7.18% rate maturing April 5, 2029. This move optimizes the capital structure, slashing dilution risks while leveraging strong cash flows for $20 million in principal payments through fiscal 2026. Interest costs will dip with rate cuts. Debt service fits comfortably.
8-K
Q1 revenues up 2.4%
Mesa Laboratories reported first-quarter fiscal 2026 revenues of $59.5 million, up 2.4% from last year, with core organic growth at 0.4%. Strong SDC and CS divisions drove gains, yet CG slumped 10.7% amid China contraction and tariffs, while BPD dipped 7.0% from shipment delays. Adjusted operating income fell 15.9% to $12.9 million, pressured by FX and costs. Management eyes revenue goals for the half-year, with Q2 profitability rebound expected. Tariffs hit 1% of revenues.
IPO
Website
Employees
Sector
Industry
A
Agilent Technologies, Inc.
139.19-1.41
BIO
Bio-Rad Laboratories, Inc.
302.02-5.90
LAB
Standard BioTools Inc.
1.49-0.02
MASS
908 Devices Inc.
5.78-0.13
MKSI
MKS Inc.
156.25-3.06
MTD
Mettler-Toledo International, I
1386.45-26.02
SCND
Scientific Industries, Inc.
0.55+0.01
TECH
Bio-Techne Corp
57.44-1.25
TMO
Thermo Fisher Scientific Inc
570.16-5.75
WAT
Waters Corporation
378.53-6.89